P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.
Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.
P3 Health Partners has successfully acquired Medcore HP and Omni IPA Medical Group, adding over 10,500 Medicare Advantage members in California. This acquisition marks P3's entry into its fifth state, enhancing its national expansion strategy.
Medcore HP is licensed under California's Knox-Keene Act, allowing it to manage global risk for its members, while Omni IPA comprises over 400 healthcare providers. CEO Sherif Abdou emphasized that this move aligns with P3's mission to improve healthcare outcomes through value-based care.
P3 Health Partners (NASDAQ: PIII) has announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022. CEO Dr. Sherif Abdou and the management team will present virtually at 5:15 p.m. ET. Interested parties can access the live webcast on P3's investor website, with a replay available afterwards. P3 focuses on patient-centered, physician-led population health management, aiming to enhance patient outcomes while reducing care costs through integrated care models and technology.
P3 Health Partners has completed its business combination with Foresight Acquisition Corp., with trading commencing on December 6, 2021, under the ticker symbols PIII and PIIIW on Nasdaq. The merger positions P3 as a public company aiming to improve population health management through its value-based care model, which focuses on empowering patients and providers. P3's management team, led by physician-experts, is committed to expanding operations and addressing significant healthcare challenges, including rising costs and access issues.